The purpose of the protocol is to achieve an in-depth understanding of the current satisfaction status of somatostatin analogue (SSA) treatment for acromegaly through patient and physician surveys.
Study Type
OBSERVATIONAL
Overall patient satisfaction with SSA treatment.
To be assessed by four levels of satisfaction including very satisfied, satisfied, dissatisfied, and very dissatisfied
Time frame: During the whole study period (approximately 3 months).
Patient satisfaction with symptom control of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Patient satisfaction with frequency of administration of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Patient satisfaction with mode of administration of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Patient satisfaction with convenience of administration of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Patient satisfaction with injection site reactions of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Patient satisfaction with adverse reactions to SSA treatment
Time frame: During the whole study period (approximately 3 months).
Physician overall satisfaction with SSA treatment.
The satisfaction rate is calculated as the proportion of physicians who reported to be satisfied or very satisfied with the prescribed SSA treatment.
Time frame: During the whole study period (approximately 3 months).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Physician satisfaction with symptom control of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Physician satisfaction with frequency of administration of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Physician satisfaction with mode of administration of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Physician satisfaction with convenience of administration of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Physician satisfaction with injection site reactions of SSA treatment
Time frame: During the whole study period (approximately 3 months).
Physician satisfaction with adverse reactions to SSA treatment
Time frame: During the whole study period (approximately 3 months).
Aspects of patient concern before initiating SSA treatment
The magnitude of concern will be assessed by four levels including not concerned, slightly concerned, concerned, and very concerned.
Time frame: During the whole study period (approximately 3 months).
Aspects of physician concern before prescribing SSA treatment
The magnitude of concern will be assessed by four levels including not concerned, slightly concerned, concerned, and very concerned.
Time frame: During the whole study period (approximately 3 months).
Overall patient satisfaction with SSA treatment: satisfied versus dissatisfied with their SSA treatment.
The patient satisfaction will be categorized as binary variables including satisfied (very satisfied and satisfied) versus dissatisfied (dissatisfied and very dissatisfied).
Time frame: During the whole study period (approximately 3 months).